Woyach, JA, Ghia, P, Byrd, JC, Ahn, IE, Moreno, C, O'Brien, SM, Jones, D, Cheung, LWK, Chong, ELZB, Kwei, K, Dean, JP, James, DF, Wiestner, A. B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy. CLINICAL CANCER RESEARCH. 2023; 29(16)DOI:10.1158/1078-0432.CCR-22-3887. PMID:37314786. IF:10.400(Q1/1D).

Santos-García D., Cores Bartolomé C., Feal Painceiras M.J., García Díaz I., Íñiguez Alvarado M.C., Paz J.M., García Caldentey J., Hernández Vara J., Cabo I., López Manzanares L., González Aramburu I., Ávila Rivera M.A., Gómez Mayordomo V., Dotor García-Soto J., Borrué C., Solano Vila B., Álvarez Sauco M., Mendoza Z., Martínez Castrillo J.C., Sánchez Alonso P., Alonso Losada M.G., López Ariztegui N., Alonso Redondo R., Menéndez-González M., Adarmes A.D., Almeria M., Losada M.G.A., Cánovas A.A., Frech F.A., Redondo R.A., Álvarez I., Sauco M.Á., Díaz A.A., Arnáiz S., Arribas S., Vidondo A.A., Aguilar M., Ávila M.A., Lambrich N.N., Bejr-Kasem H., Estrada M.B., Botí M., Borrue C., Buongiorno M.T., González C.C., López I.C., Caballol N., Lorenzo A.C., Medina H.C., Pendón E.C., Carrillo F., Padilla F.J.C., Casas E., Catalán M.J., Clavero P., Fernández A.C., Cosgaya M., Foraster A.C., Cuevas A.C., Cubo E., de Deus Fonticoba T., de Fábregues-Boixar O., Díez-Fairen M., García-Soto J.D., Erro E., Escalante S., Peyret E.E., Guillán N.F., Gámez P., Gallego M., Caldentey J.G., Campos C.G., Díez C.G., Moreno J.M.G., Gastón I., Garre M.P.G., Mayordomo V.G., Aloy J.G., González-Aramburu I., Ardura J.G., García B.G., Palmás M.J.G., Toledo G.R.G., Díaz A.G., Solá M.G., Guardia G., Vara J.H., Horta-Barba A., Calderón D.I., Infante J., Jesús S., Kulisevsky J., Kurtis M., Labandeira C., Labrador M.A., Lacruz F., Castro M.L., Gómez S.L., Legarda I., Ariztegui N.L., Díaz L.M.L., Domínguez D.L., Manzanares L.L., Seoane B.L., del Pozo S.L., Macías Y., Mata M., Andres G.M., Martí M.J., Castrillo J.C.M., Martinez-Martin P., McAfee D., Meitín M.T., Plasencia Z.M., González M.M., del Barrio C.M., Mir P., Santiago J.M., Casado M.I.M., Diéguez A.M., García I.M., Nogueira V., Amado A.N., Ponte S.N., Ordás C., Pagonabarraga J., Pareés I., Pascual-Sedano B., Pastor P., Fuertes A.P., Noguera R.P., Planas-Ballvé A., Planellas L., Prats M.A., Jurczynska C.P., Puente V., Morlans M.P., Daví A.P., Rafales N.R., Méndez L.R., Pérez A.B.R., Roldán F., De Arcos M.R., Martínez J.R., Alonso P.S., Sánchez-Carpintero M., Díez G.S., Rodríguez A.S., Santacruz P., García D.S., Rodríguez J.C.S., Seijo M., Peña M.S., Vila B.S., Castro E.S., Tartari J.P., Valero C., Vargas L., Vela L., Villanueva C.. Cognitive impairment and dementia in young onset Parkinson’s disease. JOURNAL OF NEUROLOGY. 2023; DOI:10.1007/s00415-023-11921-w. PMID:37578489. IF:4.800(Q1/2D).

Salazar, J, Bracchiglione, J, Savall-Esteve, O, Antequera, A, Bottaro-Parra, D, Gutierrez-Valencia, M, Martinez-Peralta, S, Pericay, C, Tibau, A, Bonfill, X. Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review. BMC CANCER. 2023; 23(1)DOI:10.1186/s12885-023-11207-4. PMID:37573294. IF:3.400(Q2/4D).

Álamo P., Parladé E., Favaro, MTP, Gallardo A., Mendoza R., Ferreira, LCS, Roher N., Mangues R., Villaverde A., Vázquez E.. Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins. ACS Applied Materials & Interfaces. 2023; 15(33)DOI:10.1021/acsami.3c08643. PMID:37614001. IF:8.500(Q1/2D).

Diest, APV, Vilagut, G, Alayo, I, Ferrer, M, Amigo, F, Amann, BL, Aragon-Pena, A, Aragones, E, Del Barco, AA, Campos, M, Del Cura-Gonzalez, I, Espuga, M, Gonzalez-Pinto, A, Haro, JM, Larrauri, A, Lopez-Fresnena, N, de Salazar, AM, Molina, JD, Orti-Lucas, RM, Parellada, M, Pelayo-Teran, JM, Perez-Zapata, A, Pijoan, JI, Plana, N, Puig, T, Rius, C, Rodriguez-Blazquez, C, Sanz, F, Serra, C, Urreta-Barallobre, I, Kessler, RC, Bruffaerts, R, Vieta, E, Perez-Sola, V, Alonso, J, Mortier, P. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study. Epidemiology and Psychiatric Sciences. 2023; 32DOI:10.1017/S2045796023000628. PMID:37555258. IF:5.900(Q1/1D).

Fagiolini A., Cardoner N., Pirildar S., Ittsakul P., Ng B., Duailibi K., El Hindy N.. Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder. EXPERT OPINION ON PHARMACOTHERAPY. 2023; 24(15)DOI:10.1080/14656566.2023.2242264. PMID:37501324. IF:2.500(Q3/6D).